Below, we explore how indication expansion is unfolding and what it means for clinical development in 2026 and beyond in obesity, oncology and cell and gene therapy
Novo Nordisks Wegovy/Ozempic [semaglutide] and Lillys Mounjaro/Zepbound [tirzepatide]) generated tens of billions in sales and vastly expanded the patient base
However, some researchers believe GLP-1 therapies may offer unique advantages
References: Anderson, L
Cruciferous vegetables such as broccoli, Brussels sprouts, cauliflower, kale, and cabbage contain components which lead to the production of Glutathione and the detoxification processes of the cells

CJC-1295: Long-acting GHRH analog that increases baseline GH levels Ipamorelin: Growth hormone secretagogue that creates GH pulses without affecting cortisol or prolactin Combined benefits: Increased lean muscle mass (5-10 pounds over 3-6 months) Enhanced fat loss (especially visceral fat) Improved recovery between training sessions Better sleep quality (GH release during deep sleep) Increased collagen synthesis (joint/tendon health) Enhanced overall body composition Dosing: CJC-1295: 200-300mcg Ipamorelin: 200-300mcg Inject together, subcutaneously, before bed 5-7 days per week Timeline: Improved sleep within 1-2 weeks Better recovery within 3-4 weeks Visible body composition changes 8-12 weeks Maximum benefits 4-6 months Best for: Men wanting lean muscle gains, improved recovery, and overall body composition optimization without the risks of growth hormone itself